Other substances

Reviparin

anticoagulant drug

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

low molecular weight heparin 

 

Supporting references

Link Tested on Impact factor Notes Publication date
SARS-CoV-2 Spike S1 Receptor Binding Domain undergoes Conformational Change upon Interaction with Low Molecular Weight Heparins.
Spike protein Preprint 		in vitro Apr/29/2020
Export (.csv)